skip to main content

Dual antiplatelet bleeding risk — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsDual antiplatelet bleeding riskGPhC CRA

A 64-year-old man discharged after coronary stent insertion is taking aspirin 75 mg daily and ticagrelor 90 mg twice daily. He asks to buy ibuprofen for back pain. He has a history of dyspepsia. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Avoid ibuprofen and discuss safer analgesia with the pharmacist or prescriber

NSAIDs increase gastrointestinal bleeding risk, particularly when combined with antiplatelet therapy. Stopping prescribed antiplatelet therapy after stenting can be dangerous and should not be advised at the counter. The safest action is to avoid ibuprofen and discuss alternatives such as paracetamol and need for gastroprotection.

Reference: BNF; NICE CKS